Stay updated on Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Sign up to get notified when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.

Latest updates to the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page
- Check6 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a revision in the content. The phrase 'Here’s how you know' has been removed and replaced with 'Here’s how you know'.SummaryDifference1.0%
- Check13 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check56 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check71 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check78 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check92 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
Stay in the know with updates to Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.